Literature DB >> 11788576

Guidelines on the management of osteoporosis associated with chronic liver disease.

Jane D Collier1, M Ninkovic, J E Compston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11788576      PMCID： PMC1867644          DOI： 10.1136/gut.50.suppl_1.i1

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  54 in total

1.  A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis.

Authors:  A Floreani; F Zappala; W Fries; R Naccarato; M Plebani; A D'Angelo; M Chiaramonte
Journal:  J Clin Gastroenterol       Date:  1997-06       Impact factor: 3.062

2.  Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.

Authors:  N Guañabens; A Parés; A Monegal; P Peris; F Pons; L Alvarez; M J de Osaba; M Roca; M Torra; J Rodés
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

Review 3.  A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update.

Authors:  R Eastell; D M Reid; J Compston; C Cooper; I Fogelman; R M Francis; D J Hosking; D W Purdie; S H Ralston; J Reeve; R G Russell; J C Stevenson; D J Torgerson
Journal:  J Intern Med       Date:  1998-10       Impact factor: 8.989

4.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

5.  Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload.

Authors:  L Sinigaglia; S Fargion; A L Fracanzani; L Binelli; N Battafarano; M Varenna; A Piperno; G Fiorelli
Journal:  J Rheumatol       Date:  1997-09       Impact factor: 4.666

Review 6.  Management of male osteoporosis: report of the UK Consensus Group.

Authors:  R Eastell; I T Boyle; J Compston; C Cooper; I Fogelman; R M Francis; D J Hosking; D W Purdie; S Ralston; J Reeve; D M Reid; R G Russell; J C Stevenson
Journal:  QJM       Date:  1998-02

7.  Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

Authors:  A Monegal; M Navasa; N Guañabens; P Peris; F Pons; M J Martinez de Osaba; A Rimola; J Rodés; J Muñoz-Gómez
Journal:  Calcif Tissue Int       Date:  1997-02       Impact factor: 4.333

8.  Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

Authors:  F J Gallego-Rojo; J L Gonzalez-Calvin; M Muñoz-Torres; J L Mundi; R Fernandez-Perez; D Rodrigo-Moreno
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

9.  Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.

Authors:  F H Anderson; R M Francis; R T Peaston; H J Wastell
Journal:  J Bone Miner Res       Date:  1997-03       Impact factor: 6.741

10.  Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

Authors:  P Angulo; T M Therneau; A Jorgensen; C K DeSotel; K S Egan; E R Dickson; J E Hay; K D Lindor
Journal:  J Hepatol       Date:  1998-11       Impact factor: 25.083
View more
  50 in total

1.  Osteoporosis and liver disease: additional reasons for coeliac disease screening.

Authors:  M Marignani; S Angeletti; S Morini
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

2.  Population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings.

Authors:  Ajay K Parsaik; Rickey E Carter; Vishwanath Pattan; Lucas A Myers; Hamit Kumar; Steven A Smith; Christopher S Russi; James A Levine; Ananda Basu; Yogish C Kudva
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 3.  Osteoporosis across chronic liver disease.

Authors:  M Guarino; I Loperto; S Camera; V Cossiga; C Di Somma; A Colao; N Caporaso; F Morisco
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

Review 4.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

5.  Management of liver cirrhosis between primary care and specialists.

Authors:  Ignazio Grattagliano; Enzo Ubaldi; Leonilde Bonfrate; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 6.  Metabolic bone disease in patients with liver disease.

Authors:  Elizabeth Carey; Vijayan Balan
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 7.  Cholestasis and metabolic bone disease - a clinical review.

Authors:  Rudolf W Gasser
Journal:  Wien Med Wochenschr       Date:  2008

8.  Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.

Authors:  Zhongbo Liu; Tianzhen Han; Haim Werner; Clifford J Rosen; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2017-11-06       Impact factor: 6.741

9.  Outcomes of community-dwelling adults without diabetes mellitus who require ambulance services for hypoglycemia.

Authors:  Ajay K Parsaik; Rickey E Carter; Lucas A Myers; Ming Dong; Ananda Basu; Yogish C Kudva
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.